Patents Assigned to Max-Planck-Gesellschft Zur Foerderung Der Wissenschaften e.V.
  • Polymorphisms in Abcb1 Associated with a Lack of Clinical Response to Medicaments
    Publication number: 20080064609
    Abstract: The present invention relates to methods, compositions and kits for determining the prognosis of a clinical response in a human patient to a medicament which acts in the central nervous system and which is a substrate of the ABCB1 protein. Further, the invention relates to a combination of medicaments for the treatment of human patients having specific polymorphisms in the ABCB1 gene.
    Type: Application
    Filed: May 12, 2005
    Publication date: March 13, 2008
    Applicant: Max-Planck-Gesellschft Zur Foerderung Der Wissenschaften e.V.
    Inventors: Manfred Uhr, Florian Holsboer, Elisabeth Binder, Bertram Mueller-Myhsok